Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology
Globe Newswire7-02-2023, 04:32
Gorilla Technology Group Hires Global Economics Group for Due Diligence, Advancing in Battle Against Illegal Short Selling; Takes Aggressive Action to Defend Stock from Manipulation 8-08-2023, 19:10